DanielPCahillMDPhD
Neurosurgery • Boston, MABrain & Spinal Tumor
Associate Professor, Neurosurgery-Massachusetts General Hospital, Harvard Medical School
Dr. Cahill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St - Yawkey9E
Massachusetts General Hospital Nsurg Hst
Boston, MA 02114Phone+1 617-724-0884Fax+1 617-724-0887- Is this information wrong?
Summary
- Dr. Daniel Cahill is a neurosurgeon in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 16 years. He specializes in brain & spinal tumor and is experienced in neurosurgical oncology, including primary brain tumors (IDH mutant glioma, astrocytoma, oligodendroglioma, and glioblastoma), metastatic brain tumors (including melanoma, lung cancer, breast cancer), and meningioma.
Education & Training
Massachusetts General HospitalResidency, Neurological Surgery, 2001 - 2008- Massachusetts General HospitalInternship, Transitional Year, 2001 - 2002
Johns Hopkins University School of MedicineClass of 2001
Certifications & Licensure
MA State Medical License 2004 - 2024
TX State Medical License 2008 - 2017- American Board of Neurological Surgery Neurological Surgery
Publications & Presentations
PubMed
- Radical surgical resection with molecular margins is associated with improved survival in IDH wildtype GBM.Elie Massaad, William J Smith, Joseph Bradley, Eric Esposito, Mihir Gupta, Evan Burns, Ryan Burns, José K Velarde, Inka K Berglar, Rajiv Gupta, Maria Martinez-Lage, Jo...> ;Neuro-Oncology. 2024 Apr 6
- 3 citationsMutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.Avishay Spitzer, Simon Gritsch, Masashi Nomura, Alexander Jucht, Jerome Fortin, Ramya Raviram, Hannah R Weisman, L Nicolas Gonzalez Castro, Nicholas Druck, Rony Chanoc...> ;Cancer Cell. 2024 Apr 2
- Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.Hua, L., Alkhatib, M., Fujio, S., Alhasan, B., Herold, S., Zeugner, S., Zolal, A., Hijazi, M., Clark, V., Wakimoto, H., Shankar, G., Brastianos, P., Barker, F., Cahill...> ;Journal of Neurosurgery. 2024 Jan 26
- Join now to see all
Journal Articles
- The Dual PI3K/mTOR-pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain MetastasesPriscilla K Brastianos, Daniel P Cahill, Clinical Cancer Research
- DMD Genomic Deletions Characterize a Subset of progressive/higher-grade Meningiomas with Poor OutcomeGanesh M Shankar, Sandro Santagata, Priscilla K Brastianos, Daniel P Cahill, Acta Neuropathologica
- Cell Surface Notch Ligand DLL3 Is a Therapeutic Target in Isocitrate Dehydrogenase Mutant GliomaJohn G Golfinos, Daniel P Cahill, Erik P Sulman, David Zagzag, Clinical Cancer Research
Press Mentions
New Targeted Glioma Therapy Could Suppress Tumor GrowthAugust 9th, 2018
Rapid Diagnostic Coupled with Local Therapy Developed for Brain TumorsAugust 6th, 2018- Molecular Approach to Brain Tumors Improves TreatmentFebruary 10th, 2016
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
